FDA approves the first drug designed to treat postpartum depression - News Summed Up

FDA approves the first drug designed to treat postpartum depression


The disorder, which begins during pregnancy or within a month of childbirth, is far more severe than the common “baby blues.” It is characterized by feelings of worthlessness or guilt, or thoughts of suicide, and can interfere with a mother's ability to bond with an infant, which can affect the baby's development.


Source: Los Angeles Times March 20, 2019 01:18 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */